secwatch.observer — SEC 8-K summary
======================================

Issuer:     CYPHERPUNK TECHNOLOGIES INC. (CYPH)
CIK:        0001509745
Form:       8-K
Filed at:   2023-04-07T23:59:59+00:00
Accession:  0001104659-23-043095
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Leap Therapeutics amends CMO's severance; boosts benefits post-change-in-control
--------------------------------------------------------------------------------

- CMO Cynthia Sirard gets 100% base salary severance (12 monthly installments) on non-Cause termination or Good Reason resignation.
- Post-change-in-control termination within 1 year: severance increases to 125% base salary (lump sum) and COBRA reimbursed for 15 months (lump sum).
- Equity awards become exercisable for up to 2 years after qualifying termination following a change in control.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1509745/000110465923043095/0001104659-23-043095-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1509745/000110465923043095/tm2312108d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-043095

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer